findmyKOL
Clinical trialNCT03496766TerminatedPhase 2Interventional

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

SponsorSpanish Lung Cancer GroupEnrollment9Non Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Complejo Hospitalario Universitario de Santiago

    Santiago de Compostela, A Coruña, Spain

  • Hospital Virgen de Los Lirios

    Alcoy, Alicante, Spain

  • Hospital General Universitario de Elche

    Elche, Alicante, Spain

  • Ico-Badalona

    Badalona, Barcelona, Spain

  • Ico-Hospitalet

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Provincial de Castellón

    Castellon, Castelló, Spain

  • Hospital Universitario Fundación Alcorcón

    Alcorcón, Madrid, Spain

  • Hospital Universitario de la Arrixaca

    El Palmar, Murcia, Spain

  • Hospital Costa del Sol

    Marbella, Málaga, Spain

  • Complejo Hospitalario de Navarra

    Pamplona, Navarre, Spain

  • Hospital Central de Asturias

    Oviedo, Principality of Asturias, Spain

  • Hospital Sant Joan de Reus

    Reus, Tarragona, Spain

  • H. Universitario de Canarias

    San Cristóbal de La Laguna, Tenerife, Spain

  • H. Clinic I Provincial

    Barcelona, Spain

  • H.U.Vall D´hebrón

    Barcelona, Spain

  • Hospital de la Santa Creu I Sant Pau

    Barcelona, Spain

  • Hospital Universitario de Ciudad Real

    Ciudad Real, Spain

  • Ico Girona -H. Dr. Josep Trueta

    Girona, Spain

  • Hospital de Jaén

    Jaén, Spain

  • Hospital Lucus Agustí

    Lugo, Spain

  • H. 12 de Octubre

    Madrid, Spain

  • Hospital la Princesa

    Madrid, Spain

  • Hospital Puerta de Hierro

    Madrid, Spain

  • H. Carlos Haya

    Málaga, Spain

  • H. Son Llàtzer

    Palma de Mallorca, Spain

  • Hospital Clinico de Salamanca

    Salamanca, Spain

  • Hospital Virgen de la Macrena

    Seville, Spain

  • H. General U. de Valencia

    Valencia, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Spain

  • Hospital la Fe

    Valencia, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 May 2018
Primary completion
30 Oct 2022
Completion
9 Nov 2022
Last update posted
5 Mar 2025
Registered enrollment
9
Registry id
NCT03496766

Cross-registrations

EU-CTR / CTIS (EudraCT)2017-004822-13

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.